106585-57-3Relevant articles and documents
Anti-cancer quinazoline derivatives
-
, (2008/06/13)
A compound of formula I: STR1 wherein R is hydrogen; oran alkyl, alkenyl or alkynyl group of up to 6 carbon atoms; nis O; 1 or 2; Z represents --CH=CH-- or --S--; each X independently represents halogeno, C1 -C4 alkyl, C1 -C4 alkoxy, nitro or trifluoromethyl; and Y represents a group of formula: STR2 or a pharmaceutically acceptable salt or ester thereof.
Quinazoline Antifolate Thymidylate Synthase Inhibitors: 2'-Fluoro-N10-propargyl-5,8-dideazafolic Acid and Derivatives with Modifications in the C2 Position
Jackman, Ann L.,Marsham, Peter R.,Thornton, Timothy J.,Bishop, Joel A. M.,O'Connor, Brigid M.,et al.
, p. 3067 - 3071 (2007/10/02)
The synthesis of 2'-fluoro-10-propargyl-5,8-dideazafolic acid and its 2-desamino, 2-desamino-2-hydroxymethyl, and 2-desamino-2-methoxy analogues is described.In general the synthetic route involved the coupling of diethyl N--L-glutamate (15) with the appropriate 6-(bromomethyl)quinazoline followed by deprotection with mild alkali.These four compounds together with the 2-desamino-2-methyl analogue were tested for their activity against L1210 thymidylate synthase (TS).They were also examined for their inhibition of the growth of the L1210 cell line and of two mutant L1210 cell lines, the L1210:R7A that overproduces dihydrofolate reductase (DHFR) and the L1210:1565 that has impaired uptake of reduced folates.Compared with their nonfluorinated parent compounds, the 2'-fluoro analogues were all ca. 2-fold more potent as TS inhibitors.Similarly, they also showed improved inhibition of L1210 cell growth (1.5-5-fold), and this activity was prevented by co-incubation with thymidine.All had retained or improved activity against both the L1210:R7A and L1210:1565 cell lines.